Targeting the Carotid Bodies to Reduce Disease Risk Along the Diabetes Continuum

Targeting the Carotid Bodies to Reduce Disease Risk Along the Diabetes Continuum

Experimental: Oral Glucose Tolerance Test
Subjects will consume a 75 g glucose drink within 1-min and monitored for 2 hours.
Other: Hyperoxia Exposure
2 hours of hyperoxia exposure during OGTT
Other: Normoxia Exposure
2 hours of normoxia exposure during OGTT

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

February 18, 2023Comments OffClinicalTrials.gov | Endocrinology Clinical Trials | Endocrinology Studies | US National Library of Medicine
Comments